| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | China | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | Brazil | 3 | |
| #6 | Canada | 3 | |
| #7 | Hong Kong | 3 | |
| #8 | Republic of Korea | 3 | |
| #9 | Australia | 1 | |
| #10 | Hungary | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Janicot Michel | 29 |
| #2 | Jaschinski Frank | 28 |
| #3 | Uhlmann Eugen | 27 |
| #4 | Leo Eugen | 6 |
| #5 | Frank Jaschinski | 4 |
| #6 | Michel Janicot | 4 |
| #7 | Eugen Uhlmann | 3 |
| #8 | Fettes Petra | 3 |
| #9 | Wosikowski-Buters Katja | 3 |
| #10 | Schneider Anneliese | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3538655A1 | Tgf-beta oligonucleotide for use in treatment of ophthalmic diseases | |
| US2016060632A1 | Modified TGF-beta2 oligonucleotides | |
| CN105378083A | Modified tgf-beta oligonucleotides | |
| KR20150140702A | Modified tgf-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease |